- Report
- October 2024
- 189 Pages
Global
From €3270EUR$3,545USD£2,773GBP
€3633EUR$3,939USD£3,081GBP
- Report
- February 2025
- 200 Pages
Global
From €4141EUR$4,490USD£3,512GBP
- Report
- May 2025
- 193 Pages
Global
From €5396EUR$5,850USD£4,576GBP
- Report
- May 2025
- 197 Pages
Global
From €5396EUR$5,850USD£4,576GBP
- Report
- June 2022
- 200 Pages
Global
From €4426EUR$4,799USD£3,754GBP
- Report
- November 2022
- 270 Pages
Global
From €5441EUR$5,899USD£4,614GBP
- Book
- February 2019
- 512 Pages
- Book
- June 2019
- 688 Pages
Hot Melt Extrusion (HME) is a process used in drug discovery to produce drug-loaded polymeric materials. It is a continuous process that involves melting and mixing of polymers and active pharmaceutical ingredients (APIs) at high temperatures. The resulting material is then extruded through a die to form a solid product. HME is used to produce drug-loaded polymeric materials with improved bioavailability, solubility, and stability. It is also used to produce drug-loaded polymeric materials with controlled release profiles.
HME is a cost-effective and efficient method for producing drug-loaded polymeric materials. It is also a versatile process that can be used to produce a wide range of drug-loaded polymeric materials.
Some companies in the Hot Melt Extrusion market include Elmarco, Thermo Fisher Scientific, and GEA Group. Show Less Read more